JusA.VilleneuveA.GauthierJ.PieresA.CoteJ. M.JusK.VilleneuveR., and PerronD., Influence of Lithium Carbonate on Patients with Temporal Lobe Epilepsy, Canadian Psychiatry Assoc. J., 18:77–78, 1973.
3.
ErwinC. W.GerberC. J.MorrisonS. D., and JamesJ. F., Lithium Carbonate and Convulsive Disorders, Arch. Gen. Psychia., 28:646–648, 1973.
4.
GershonS., and YumilerA., Lithium Ion: A Specific Psychopharmacological Approach to the Treatment of Mania, J. Neuropsychiat., 1:229–241, 1960.
5.
BaldessariniR., and StephensJ., Lithium Carbonate For Affective Disorders. Clinical Pharmacology and Toxicology, J. Arch. Gen. Psychiat., 22:72–77, 1970.
6.
DemersR.LukeshR., and PrichardJ., Convulsion During Lithium Therapy, Lancet, 2:315–316, 1970.
7.
CraneP.O., and SwansonP. D., Diphenylhydantoin and the Cations and Phosphates of Electrically Stimulated Brain Slices, Neurology, 20:1119–1123, 1970.
8.
WoodburyD. M., Mechanisms of Action of Anticonvulsants. In; Basic Mechanisms of the Epilepsies, JasperWardPope, eds., Little Brown Co., 1969.
9.
JonesG. L., and KempJ. W., Characteristics of the Hydrogen Bonding Inter-Actions of Substituted Hydantoins with 9-Ethyladenine, Mol. Pharmacol., 10:48–56, 1973.
10.
YanagiharaT., and HambergerA., Effect of Diphenylhydantoin on Protein Metabolism in the Central Nervous System, Exp. Neurol., 31:87–89, 1971.
11.
RapportR.II, and OjemanG. A., Prophylactically Administered Phenytoin,, Arch. Neurol., 32:539–548, 1975.
12.
RapportR.IIHarrisA.FrielP. N., and OjemanG. A., Human Epileptic Brain, Arch. Neurol., 32:549–554, 1975.
13.
FornJ., and ValdecasasF. G., Effects of Lithium on Brain Adenylcyclase Activity, Biochemical Pharmacol., 20:2773–2779, 1971.
14.
UzunoffP., and WeissB., Psychopharmacological Agents and the Cyclic AMP System in Rat Brain. In: Advances in Cyclic Neucleotide Research, GreengardP.PaolettiR.RobinsonG. A. eds., Vol. 1, Raven Press, N. Y., 1972.
15.
IchiokaM., The Effects of Na, K, Ca, and Li Upon Threshold and “Latency” At a Node of RANVIER, Jap. J. Physiol., 5:222–230, 1955–56.
